Plain-English translation of NCT06107010 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a robotic exoskeleton called Atalante that helps patients walk during the early weeks after stroke. The exoskeleton is a wearable device that supports your legs and helps you practice walking with guidance and assistance. Researchers want to see if using this device three times a week for six weeks helps stroke patients recover walking ability faster and better than those who only receive standard physical therapy.
After a stroke, many patients struggle to walk or cannot walk at all during the critical early weeks of recovery. This trial exists to find out whether combining robotic assistance with standard therapy can help more patients regain meaningful walking ability during this important time window.
You likely qualify if…
You likely don't qualify if…
If you join the exoskeleton group, you will use the Atalante device during three one-hour sessions per week while also doing two one-hour sessions of standard physical therapy per week, for a total of six weeks. If you join the standard therapy group, you will attend five one-hour sessions per week of conventional physical therapy for six weeks. Throughout the study, therapists will monitor your progress and gradually increase the difficulty of your walking exercises.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France
Germany
Spain